• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西统一卫生系统米纳斯药房项目与巴西大众药房的经济评估。

Economic evaluation of the Programs Rede Farmácia de Minas do SUS versus Farmácia Popular do Brasil.

作者信息

Garcia Marina Morgado, Guerra Augusto Afonso, Acúrcio Francisco de Assis

机构信息

Faculdade de Farmácia, Universidade Federal de Minas Gerais. R. Professor Moacir Gomes de Freitas s/n, Pampulha. 31270-901 Belo Horizonte MG Brasil.

出版信息

Cien Saude Colet. 2017 Jan;22(1):221-233. doi: 10.1590/1413-81232017221.15912015.

DOI:10.1590/1413-81232017221.15912015
PMID:28076545
Abstract

We conducted an economic assessment of the Pharmaceutical Assistance - Rede Farmácia de Minas Gerais-RFMG and Farmácia Popular do Brasil-FPB to ascertain which of the two models stands out as the most efficient. To do this, a model, which consisted of a study of incurred costs in both programs, up to the dispensing of medicine to citizens, was developed. The uncertainties of the proposed model were tested using the Monte Carlo method. If the entire population initially estimated in the RFMG were attended in the FPB, there would be an additional cost of R$ 139,324,050.19. The sensitivity analysis appeared to be favorable to the RFMG. A total of 10000 simulations were carried out, resulting in a median value of R$ 114,053,709.99 for the RFMG and R$ 254,106,120.65 for the FPB. The current National Drug Policy emphasizes the need to strengthen pharmaceutical services beyond the mere acquisition and delivery of pharmaceutical products. The public healthcare service model, consistent with the principles and guidelines of the SUS, seems to be more appropriate in ensuring complete and universal quality healthcare services to the citizens. The economic study conducted reinforces this fact, as it appears to be a more efficient alternative of the direct use of resources in the public health network.

摘要

我们对米纳斯吉拉斯州药品援助计划(RFMG)和巴西大众药房计划(FPB)进行了经济评估,以确定这两种模式中哪一种最为高效。为此,我们开发了一个模型,该模型包括对两个项目中直至向公民发放药品为止所产生成本的研究。使用蒙特卡洛方法对所提议模型的不确定性进行了测试。如果最初在RFMG中估计的全部人口都由FPB来服务,将会产生额外成本139,324,050.19雷亚尔。敏感性分析似乎有利于RFMG。总共进行了10000次模拟,得出RFMG的中位数为114,053,709.99雷亚尔,FPB的中位数为254,106,120.65雷亚尔。当前的国家药品政策强调,除了单纯采购和交付药品之外,还需要加强药品服务。与统一卫生系统(SUS)的原则和准则相一致的公共医疗服务模式,似乎更适合为公民确保全面和普遍的优质医疗服务。所进行的经济研究强化了这一事实,因为它似乎是在公共卫生网络中更有效地直接利用资源的一种选择。

相似文献

1
Economic evaluation of the Programs Rede Farmácia de Minas do SUS versus Farmácia Popular do Brasil.巴西统一卫生系统米纳斯药房项目与巴西大众药房的经济评估。
Cien Saude Colet. 2017 Jan;22(1):221-233. doi: 10.1590/1413-81232017221.15912015.
2
Comments on "The organization of pharmaceutical services by 'health region' in Brazil's Unified Health System".对《巴西统一卫生系统中“健康区域”的药学服务组织》的评论
Cien Saude Colet. 2017 Apr;22(4):1181-1191. doi: 10.1590/1413-81232017224.27042016.
3
Access to medicines in the Brazilian Unified Health System's primary health care: assessment of a public policy.巴西统一卫生系统初级卫生保健中的药品获取:公共政策评估。
J Comp Eff Res. 2021 Jul;10(10):869-879. doi: 10.2217/cer-2021-0026. Epub 2021 May 25.
4
"Farmácia Popular do Brasil" Program: characterization and evolution between 2004 and 2012.“巴西大众药房”项目:2004年至2012年的特征与演变
Cien Saude Colet. 2015 Oct;20(10):2943-56. doi: 10.1590/1413-812320152010.17352014.
5
Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications.提高巴西初级卫生保健中药物供应的策略:发现与启示。
J Comp Eff Res. 2021 Feb;10(3):243-253. doi: 10.2217/cer-2020-0125. Epub 2021 Feb 5.
6
Hipoglicemiantes Orais Para Diabetes Mellitus Tipo 2: Comparação de Preços no Brasil e em Outros Sistemas Universais de Saúde.用于2型糖尿病的口服降糖药:巴西与其他全民健康保险体系的价格比较
Value Health Reg Issues. 2018 Dec;17:135-141. doi: 10.1016/j.vhri.2018.01.008. Epub 2018 Jun 20.
7
State health managers' perceptions of the Public Health Action Organizational Contract in the State of Ceará, Brazil.巴西塞阿拉州卫生管理人员对《公共卫生行动组织契约》的看法。
Cien Saude Colet. 2017 Apr;22(4):1235-1244. doi: 10.1590/1413-81232017224.26982016.
8
Health and innovation: economic dynamics and Welfare State in Brazil.健康与创新:巴西的经济动态与福利国家
Cad Saude Publica. 2016 Nov 3;32Suppl 2(Suppl 2):e00150115. doi: 10.1590/0102-311X00150115.
9
[Access to medicines for Alzheimer's disease provided by the Brazilian Unified National Health System in Minas Gerais State, Brazil].[巴西米纳斯吉拉斯州巴西统一国家卫生系统提供的阿尔茨海默病药物获取情况]
Cad Saude Publica. 2016 Aug 1;32(7):e00060615. doi: 10.1590/0102-311X00060615.
10
Financing of Pharmaceutical Services in the municipal management of the Brazilian Unified Health System.巴西统一卫生系统市政管理中的药品服务融资
Rev Saude Publica. 2017 Nov 13;51(suppl 2):14s. doi: 10.11606/S1518-8787.2017051007060.

引用本文的文献

1
How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?新冠疫情如何影响巴西的抗菌药物消费和细菌耐药情况?
Antibiotics (Basel). 2023 Aug 28;12(9):1374. doi: 10.3390/antibiotics12091374.
2
Community pharmacies and pharmacists in Brazil: A missed opportunity.巴西的社区药房和药剂师:一个错失的机遇。
Pharm Pract (Granada). 2021 Apr-Jun;19(2):2467. doi: 10.18549/PharmPract.2021.2.2467. Epub 2021 Jun 22.
3
Medication adherence and persistence of psoriatic arthritis patients treated with biological therapy in a specialty pharmacy in Brazil: a prospective observational study.
巴西一家专科药房中接受生物疗法治疗的银屑病关节炎患者的药物依从性和持续性:一项前瞻性观察研究。
Pharm Pract (Granada). 2021 Apr-Jun;19(2):2312. doi: 10.18549/PharmPract.2021.2.2312. Epub 2021 May 28.
4
Free access to medicines among older adults in primary care: a cross-sectional study.基层医疗中老年人免费获取药物情况:一项横断面研究。
Sao Paulo Med J. 2020 Jun;138(3):235-243. doi: 10.1590/1516-3180.2019.0541.R1.19022020. Epub 2020 Jun 22.
5
Hypertension and diabetes treatment affordability and government expenditures following changes in patient cost sharing in the "Farmácia popular" program in Brazil: an interrupted time series study.巴西“平价药房”项目改变患者自付费用后高血压和糖尿病治疗的可负担性和政府支出:一项中断时间序列研究。
BMC Public Health. 2020 Jan 8;20(1):24. doi: 10.1186/s12889-019-8095-0.
6
Public procurement of medicines: scoping review of the scientific literature in South America.药品的公共采购:南美洲科学文献的范围综述
J Pharm Policy Pract. 2019 Sep 18;12:33. doi: 10.1186/s40545-019-0195-9. eCollection 2019.
7
Impacts of a Brazilian pharmaceutical program on the health of chronic patients.巴西一项制药计划对慢性病患者健康的影响。
Rev Saude Publica. 2019 Jan 31;53:20. doi: 10.11606/S1518-8787.2019053000733.
8
Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil.从卫生系统角度审视巴西不断发展的大众药房药品获取计划。
BMJ Glob Health. 2018 Feb 7;2(Suppl 3):e000547. doi: 10.1136/bmjgh-2017-000547. eCollection 2017.
9
Integrality of the therapeutic and pharmaceutical care: a necessary debate.治疗与药学护理的整体性:一场必要的辩论。
Rev Saude Publica. 2017 Dec 11;51:126. doi: 10.11606/S1518-8787.2017051000185.
10
Financing of Pharmaceutical Services in the municipal management of the Brazilian Unified Health System.巴西统一卫生系统市政管理中的药品服务融资
Rev Saude Publica. 2017 Nov 13;51(suppl 2):14s. doi: 10.11606/S1518-8787.2017051007060.